Spitalul Clinic Cf Nr.2 Bucuresti

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Endometrial cancer1 trial
• Metastatic breast cancer1 trial
• Psoriasis1 trial

Phase

• Phase 32 trials
• Phase 2/31 trial

Status

• Completed1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Bristol-Myers Squibb1 trial
• Kartos Therapeutics Inc.1 trial
• Rovi Pharmaceuticals Laboratories1 trial

Running trials

• Not yet recruiting

  A Study to Investigate the Efficacy and Safety of Letrozole SIE Compared With Femara® (Both Combined With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast Cancer

  NCT07340658· Phase 3· Rovi Pharmaceuticals Laboratories· Source

• Recruiting

  Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

  NCT07116967· Phase 3· Bristol-Myers Squibb· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Metastatic breast cancer1 recruiting
• Psoriasis1 recruiting

Closed trials

• Completed

  Phase 2/3 Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

  2022-502196-31-00· Phase 2/3· Kartos Therapeutics Inc.· Source